Treatment of Gluteal Muscle Tear with PRP
The evidence is uncertain regarding PRP for acute gluteal muscle tears, but for chronic gluteal tendinopathy (>4 months), a single ultrasound-guided intratendinous leucocyte-rich PRP injection provides superior pain relief and functional improvement compared to corticosteroid injection, with sustained benefits at 2 years. 1
Key Clinical Distinction
First, clarify whether you're treating:
- Acute muscle tear (traumatic injury, <3 months): Evidence is uncertain 1
- Chronic gluteal tendinopathy (>4 months duration): Evidence supports PRP 2, 3
For Chronic Gluteal Tendinopathy (>4 Months)
Patient Selection Criteria
- Lateral hip pain >4 months duration
- Clinical diagnosis confirmed by ultrasound or MRI showing tendinosis or partial-thickness tears
- Exclude: Full-thickness tears, hip osteoarthritis, previous surgery, sciatica 2, 3
- Typical patient: ~60 years old, female predominance (9:1), BMI ~27 2
Treatment Protocol
Use leucocyte-rich PRP (LR-PRP) with single intratendinous injection under ultrasound guidance 2, 3
The evidence strongly favors this approach:
- At 12 weeks: Modified Harris Hip Score improved to 74.05 vs 67.13 with corticosteroid (p=0.048) 3
- At 24 weeks: Further improvement to 77.60 vs 65.72 with corticosteroid (p=0.0003) 2
- At 2 years: Sustained improvement to 82.59 from baseline 53.77 (p<0.0001) 2
- 82% achieved minimal clinically important difference vs 56.7% with corticosteroid 3
Critical Preparation Standards
While PRP preparations are poorly standardized 1, the successful studies used:
- Avoid EDTA anticoagulant 1
- Document platelet concentration, purity (RBC/WBC contamination), and activation status 1
- Leucocyte-rich formulation was specifically effective in gluteal tendinopathy 2
For Acute Muscle Tears
The evidence is uncertain for acute gluteal muscle injuries specifically 1. However, recent meta-analyses on acute muscle injuries (predominantly hamstring) show:
- Reduced reinjury risk (RR 0.84,95% CI 0.76-0.92) with high-certainty evidence 4
- Faster return to sport by ~7.5 days (p<0.001) 5
- Similar safety profile to controls 4, 5
If considering PRP for acute gluteal muscle tear: Use the same ultrasound-guided intratendinous approach, recognizing this extrapolates from hamstring data rather than gluteal-specific evidence.
Important Caveats
What the Guidelines Say
The 2018 ISTH consensus and 2019 AAOS recommendations emphasize 6, 1:
- PRP clinical use has outpaced evidence 6
- Autologous PRP is clinically safe 1
- Clinical preparations are poorly standardized 1
- Content, purity, and biological properties vary widely and impact efficacy 1
Practical Pitfalls to Avoid
- Don't use PRP for full-thickness gluteal tendon tears - no evidence supports this; surgery is indicated 7
- Don't expect immediate results - corticosteroid provides faster initial relief (peaks at 6 weeks), but PRP surpasses it by 12 weeks 2, 3
- Don't use multiple injections initially - single injection was effective in high-quality RCTs 2, 3
- Don't skip ultrasound guidance - all successful studies used image-guided intratendinous injection 2, 3, 8
When PRP May Not Be Appropriate
- Full-thickness tears (consider surgery) 7
- Concurrent hip osteoarthritis 3
- Symptoms <4 months (insufficient evidence for acute phase)
- Patient unable to comply with post-injection activity modification
Expected Timeline
- Minimal improvement: 0-6 weeks
- Significant improvement: 12-24 weeks
- Peak benefit: 52-104 weeks 2
- Sustained at 2 years 2
Bottom line: For chronic gluteal tendinopathy, PRP is supported by Level 1 evidence with sustained 2-year benefits. For acute tears, evidence is extrapolated from other muscle groups and remains uncertain for gluteal-specific injuries.